These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2520552)

  • 1. The role of red blood cell antigens, histocompatibility antigens, and blood transfusions on renal allograft survival.
    Blajchman MA; Singal DP
    Transfus Med Rev; 1989 Jul; 3(3):171-9. PubMed ID: 2520552
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of virus types of RBC transfusions on HLA alloimmunization and renal allograft survival.
    Fuller TC; Delmonico FL; Cosimi AB; Huggins CE; King M; Russell PS
    Transplant Proc; 1977 Mar; 9(1):117-9. PubMed ID: 325743
    [No Abstract]   [Full Text] [Related]  

  • 3. Soluble HLA and anti-idiotypic antibodies in transplantation: modulation of anti-HLA antibodies by soluble HLA antigens from the graft and anti-idiotypic antibodies in renal and cardiac allograft recipients.
    Suciu-Foca N; Ho E; King DW; Yu YP; Yu-Kai S; Reed E; Cohen D; Brensilver JM; McCabe R; Rose E
    Transplant Proc; 1991 Feb; 23(1 Pt 1):295-6. PubMed ID: 1990536
    [No Abstract]   [Full Text] [Related]  

  • 4. Evidence that HLA class II disparity is required for the induction of renal allograft enhancement by donor-specific blood transfusions in man.
    Lazda VA; Pollak R; Mozes MF; Barber PL; Jonasson O
    Transplantation; 1990 Jun; 49(6):1084-7. PubMed ID: 2360251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed elimination of donor red blood cells is associated with host major histocompatibility complex and donor-specific blood transfusion enhancement of rat renal allograft survival.
    Wasowska B; Baldwin WM; Sanfilippo F
    Transplant Proc; 1993 Feb; 25(1 Pt 1):241-2. PubMed ID: 8438285
    [No Abstract]   [Full Text] [Related]  

  • 6. Reliability of HLA typing on peripheral blood lymphocytes in cadaveric organ donors and the impact of blank donor antigens on kidney graft survival.
    Offermann G; Bünte S; Angelides U; Geidner U; Kirschbaum B; Müller E; Wendt N
    Transplant Proc; 1992 Dec; 24(6):2488-9. PubMed ID: 1361261
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of HLA semi-identical pretransplant blood transfusions on renal allograft outcome.
    Mariat C; Alamartine E; De Filippis JP; Deprele C; Le Petit JC; Goure D; Berthoux F
    Transplant Proc; 2000 Mar; 32(2):381-3. PubMed ID: 10715446
    [No Abstract]   [Full Text] [Related]  

  • 8. Anti-class II antibody production prolongs renal allograft survival.
    Lewis RE; Brackin MN; Cruse JM; Brackin BT; Butkus D; Raju S; Crawford M; Krueger R; Kirchner K; Bower J
    Pathol Immunopathol Res; 1989; 8(5-6):287-99. PubMed ID: 2633201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The putative mechanism of the immunomodulating effect of HLA-DR shared allogeneic blood transfusions on the alloimmune response.
    Waanders MM; Roelen DL; Brand A; Claas FH
    Transfus Med Rev; 2005 Oct; 19(4):281-7. PubMed ID: 16214017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of anti-HLA antibodies on the long-term survival of heart and kidney allografts.
    Barr ML; Cohen DJ; Benvenisty AI; Hardy M; Reemtsma K; Rose EA; Marboe CC; D'Agati V; Suciu-Foca N; Reed E
    Transplant Proc; 1993 Feb; 25(1 Pt 1):262-4. PubMed ID: 8438294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood transfusions and their influence on renal allograft survival.
    Rodey GE
    Prog Hematol; 1986; 14():99-122. PubMed ID: 3511519
    [No Abstract]   [Full Text] [Related]  

  • 12. Donor-specific and random transfusions in HLA-haploidentical kidney transplantation.
    Garcia LF; Arango AM; Rezonzew R; Correa M; Angel B; Guzman B; Paris SC; Arbelaez M; Henao JE; Mejia G
    Transplant Proc; 1991 Apr; 23(2):1744-6. PubMed ID: 2053141
    [No Abstract]   [Full Text] [Related]  

  • 13. Association between long-term kidney graft survival and the presence of pre-transplant cytotoxic anti-HLA and/or non-MHC 'Fc gamma RII blocking' (anti-TLX) alloantibody.
    Padányi A; Gyódi E; Rajczy K; Perner F; Petrányi GG
    Clin Transplant; 1996 Oct; 10(5):455-60. PubMed ID: 8930462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Donor-specific transfusions in renal transplantation.
    Barber WH
    Clin Transplant; 1994 Apr; 8(2 Pt 2):204-6. PubMed ID: 8019037
    [No Abstract]   [Full Text] [Related]  

  • 15. Renal transplantation.
    Ting A
    Curr Opin Immunol; 1989 Aug; 1(6):1191-4. PubMed ID: 2679757
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative results of a randomized transfusion of HLA-5, -6 mismatched (one unit) versus HLA semi-identical (one unit) blood in first renal allograft recipients.
    Touchard G; Hurault de Ligny B; Griveau AM; Pujo M; Jollet I; Lobbedez T; Bauwens M; Bridoux F; Alcalay D
    Transplant Proc; 2000 Dec; 32(8):2771-2. PubMed ID: 11134796
    [No Abstract]   [Full Text] [Related]  

  • 17. Transfusion of one HLA-DR antigen-matched blood to potential recipients of a renal allograft.
    Middleton D; Martin J; Douglas J; McClelland M
    Transplantation; 1994 Oct; 58(7):845-8. PubMed ID: 7940720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Both self and non-inherited maternal HLA antigens influence the immune response.
    van Rood JJ; Claas F
    Immunol Today; 2000 Jun; 21(6):269-73. PubMed ID: 10825738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA antigens and blood transfusion: effect on renal transplants.
    Perkins HA
    Transplant Proc; 1977 Mar; 9(1 Suppl 1):229-32. PubMed ID: 324051
    [No Abstract]   [Full Text] [Related]  

  • 20. The influence of HLA matching on renal allograft survival at a single pediatric center.
    McMullin ND; Aliabadi H; McLorie GA; Churchill BM
    J Pediatr Surg; 1989 Dec; 24(12):1278-82. PubMed ID: 2593060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.